HealthUnited StatesA serious medical-device correction and several active food recalls remained material; no confirmed harms were reported in the available notices.

FDA Alerts and Recalls

Preparing article image…

The most material active notice was Medline’s correction of convenience kits containing B. Braun bupivacaine components. Food recalls involving glass, Salmonella and undeclared allergens also remained active.

86% ConfidenceRecall existence, dates, product categories and stated hazards come from primary FDA records; several lot, class, distribution and harm details were unavailable in the retrieved summaries.

Published in edition Aug 22, 2026, 2:57 AM Pacific

What changed

No wholly new FDA notice was identified after 2026-08-21T09:57:49Z, but the August 20 Medline medical-device correction remained materially active and therefore warranted a distinct FDA topic.

Why it matters

Convenience kits containing affected anesthetic components are used in clinical care, while glass, Salmonella and undeclared-allergen hazards can cause preventable injury or illness.

What to watch next

FDA enforcement reports for classification and lot details, manufacturer customer letters, MedWatch reports and recall-status updates.

What we know

On August 20, FDA posted a confirmed recall/correction involving Medline convenience kits containing B. Braun bupivacaine hydrochloride components.
The public index did not provide a recall class, affected lot list, initiation date, distribution scope or harm denominator in the retrieved summary; these are explicitly not reported here.
On August 18, FDA posted Dreyer’s Grand Ice Cream’s voluntary recall of Outshine Fruit Bars for possible glass contamination.
Active August 17 notices included Oma’s Pride canine food for Salmonella, Prolon almond and cocoa spread for undeclared tree nuts, and Dairyland Produce jalapeños for potential Salmonella.

Material unknowns

Medline lot, model and kit identifiers
FDA recall class and initiation date
Geographic distribution and units affected
Recovery percentage and termination date

U.S. strategic assessment

High interest

The notices demonstrate active FDA surveillance and company recall activity. FDA posting of a company announcement establishes the announcement and recommended action, not independent proof that every stated hazard caused harm.

Objectives

Rapidly identify and remove unsafe products
Communicate exact identifiers and actions
Confirm scope, classification and harm counts
Monitor recall effectiveness and adverse events

Strategy

FDA public alerts and enforcement reporting
Voluntary company removals or corrections
MedWatch adverse-event intake
Follow-up classification and recall-effectiveness monitoring

Outcomes

FDA posted the Medline correction as Recall Confirmed.
Multiple food recalls remained active.
No illnesses, serious injuries or deaths were reported in the retrieved summaries for the included notices; where notice-level counts were unavailable, they are recorded as not reported.

Risks